ARCH Venture Fund XII, L.P. 13D/13G Filings for Prime Medicine, Inc. (PRME)

ARCH Venture Fund XII, L.P. 13D and 13G filings for Prime Medicine, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-22
5:32 pm
Purchase		 2024-11-12 13D Prime Medicine, Inc.
PRME		 ARCH Venture Fund XII, L.P. 15,511,736
11.800%		 39,062increase
(+0.25%)		 Filing
2024-02-22
9:31 pm
Purchase		 2024-02-15 13D Prime Medicine, Inc.
PRME		 ARCH Venture Fund XII, L.P. 15,472,674
12.900%		 15,472,674increase
(New Position)		 Filing